Despite reduced expression correlating with worse outcomes, patients with DLBCL or STAD still showed significantly higher levels of PSMD1 mRNA compared with normal controls (Figure S1F,G), and patients with THYM showed higher levels of PSMD3 compared with controls (Figure S2C). Here, PSMD1 is linked to diffuse large B-cell lymphoma.